INTENT  (EXPECTED  OUTCOMES)

  • Rapid evaluation and transfer to site with antivenom capability for envenomation
  • Tetanus prophylaxis when appropriate

PERFORMANCE/ADHERENCE  MEASURES

  • Transfer of patients with moderate to severe symptoms (grades 3 and 4) to antivenom if not available at site
  • Aggressive use of benzodiazepines as indicated for agitation, neuromuscular stimulation, tachycardia, and hypertension
  • Tetanus prophylaxis for all bites and stings

DATA  SOURCE

  • Patient record
  • Department of Defense Trauma Registry (DoDTR)

SYSTEM  REPORTING  &  FREQUENCY

The above constitutes the minimum criteria for PI monitoring of this CPG. System reporting will be performed annually. Additional PI monitoring and system reporting may be performed as needed.

The system review and data analysis will be performed by the JTS Chief, JTS Program Manager and the JTS PI Branch.

RESPONSIBILITIES

It is the clinical team leader’s responsibility to ensure familiarity, appropriate compliance, and PI monitoring at the local level with this CPG.